The importance of clinical prediction models in non-fatal pulmonary embolism: an analysis of the best known clinical scores

Revista medico-chirurgicală̆ a Societă̆ţ̜ii de Medici ş̧i Naturaliş̧ti din Iaş̧i

Volumn 118, Issue 4, 2014, Pages 932-941

  Ouatu, Anca ^a   Tănase, Daniela M aria ^a   Ionescu, Simona D aniela ^a   Rezus C ^a   Ambarus V ^a   Arsenescu Georgescu, Cătălina ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

BLOOD; DECISION SUPPORT SYSTEM; DIFFERENTIAL DIAGNOSIS; EVIDENCE BASED MEDICINE; HUMAN; META ANALYSIS (TOPIC); METABOLISM; MORTALITY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PROGNOSIS; PULMONARY EMBOLISM; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

ANTICOAGULANTS; ANTIFIBRINOLYTIC AGENTS; BIOLOGICAL MARKERS; DECISION SUPPORT TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; GUIDELINES AS TOPIC; HUMANS; META-ANALYSIS AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY EMBOLISM; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84925283009     PISSN: 00487848     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)